Brean Capital Raises Price Target on Lemaitre Vascular (LMAT) to $20
Tweet Send to a Friend
Brean Capital reiterated a Buy rating on LeMaitre Vascular (NASDAQ: LMAT), and raised the price target to $20.00 (from $17.50) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE